DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market Analysis (2018-2024)" report has been added to ResearchAndMarkets.com's offering.
The Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market is expected to witness market growth of 31.8% CAGR during the forecast period (2018-2024).
MIGS devices is expected to be most preferred surgical modality during the forecast period to treat glaucoma. It limits the dependency on conventional medications as well as cuts the complications associated with traditional procedures. Glaucoma is a progressive disease and is the major cause of irreversible blindness with an estimated burden to rise 111.8 million by 2040. This has increased the demand for MIGS devices in the treatment of glaucoma.
The factors driving the market include rapid rise in geriatric population, who are more prone to ophthalmology diseases such as glaucoma and cataract. The novel paradigm of glaucoma therapy by using MIGS devices will aspire to a much reduced dependence on topical medication. In addition, increasing preference of surgeons for MIGS is adding boost to the market growth.
Segments Covered
- On the basis of Surgery, the market is segmented into Glaucoma in Conjunction with Cataract and Stand Alone Glaucoma.
- Target is categorized into Trabecular Meshwork, Suprachoroidal Space and Other Targets.
- On the basis of Product, the market is segmented into MIGS Stents, MIGS Shunts and Other Products.
- The End Users covered under the report are Eye Hospitals, Ophthalmology Clinics and Others.
- Based on Countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Key Topics Covered
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Surgery
Chapter 4. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Target
Chapter 5. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Product
Chapter 6. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by End User
Chapter 7. Asia Pacific Minimally Invasive Glaucoma Surgery (MIGS) Devices Market by Country
Chapter 8. Company Profiles
- Ellex Medical Lasers Ltd.
- Allergan PLC
- Santen Pharmaceutical Co. Ltd.
- Glaukos Corporation
- Alcon Inc. (Novartis)
- Lumenis
- Ivantis Inc.
- iSTAR Medical
- InnFocus Inc.
- SOLX Inc.
For more information about this report visit https://www.researchandmarkets.com/research/ftn4pt/_minimally?w=4
